The cost effects of protocol systems. The marginal cost-average cost dichotomy

S A Finkler1, D Schwartzben

  • 1Program in Health Policy and Management, Graduate School of Public Administration, New York University, NY 10003.

Medical Care
|September 1, 1988
PubMed

Insights

Protocol systems can improve patient care quality and efficiency. However, this study found pediatric protocol systems offer substantial average cost savings but minimal marginal cost reduction, challenging assumptions about their cost-saving potential.

Area of Science:

  • Health Economics
  • Pediatric Healthcare Management
  • Clinical Protocol Analysis

Background:

  • Protocol systems are proposed to enhance patient care quality, efficiency, and cost-effectiveness.
  • Previous cost analyses often relied on average costs, potentially overestimating savings.

Purpose of the Study:

  • To analyze the cost effects of a pediatric protocol system.
  • To differentiate between average and marginal cost impacts of protocol adherence.

Main Methods:

  • Comparative cost analysis of protocol-adherent versus non-adherent pediatric care.
  • Examination of ancillary department costs and their variability.
  • Assessment of labor resource reallocation and equipment reconfiguration.

Main Results:

  • Protocol-adherent care demonstrated substantial savings when measured against average costs.
  • A minimal decrease in the marginal cost of care was observed.
  • Ancillary department costs remained largely fixed, unaffected by protocol-driven volume changes.

Conclusions:

  • Pediatric protocol systems can achieve significant average cost reductions.
  • The marginal cost savings from protocol adherence are limited.
  • While valuable for care appropriateness, protocol systems' cost-reduction capabilities may be overestimated.

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
Pharmacodynamic Models: Logarithmic Concentration–Effect Model01:15

Pharmacodynamic Models: Logarithmic Concentration–Effect Model

The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration, limiting its...
Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...